Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 28, 2011 - Issue 1
Submit an article Journal homepage
161
Views
16
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLEBenign Hematology

Approaches to Transfusion Therapy and Iron Overload in Patients with Sickle Cell Disease: Results of an International Survey

Elliott P. VichinskyChildren's Hospital & Research Center Oakland, California, USACorrespondence[email protected]
,
Kwaku Ohene-FrempongChildren's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
&
The Transfusion Committee(see Appendix)
Pages 37-42 | Published online: 30 Jul 2010

REFERENCES

  • National Institutes of Health (NHLBI). The Management of Sickle Cell Disease. Bethesda, MD: National Institutes of Health; 2002. NIH publication no 02–2117.
  • Adams RJ, McKie VC, Hsu L, Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339:5–11.
  • Adams RJ, Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005;353:2769–2778.
  • Vichinsky E, Butensky E, Fung E, Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia. Am J Hematol. 2005;80:70–74.
  • Darbari DS, Kple-Faget P, Kwagyan J, Circumstances of death in adult sickle cell disease patients. Am J Hematol. 2006;81:858–863.
  • Borgna-Pignatti C, Cappellini MD, De Stefano P, Survival and complications in thalassemia. Ann N Y Acad Sci. 2005;1054:40–47.
  • Modell B, Khan M, Darlison M. Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet. 2000;355:2051–2052.
  • Silliman CC, Peterson VM, Mellman DL, Iron chelation by deferoxamine in sickle cell patients with severe transfusion-induced hemosiderosis: a randomized, double-blind study of the dose-response relationship. J Lab Clin Med. 1993;122:48–54.
  • Cohen AR, Martin MB. Iron chelation therapy in sickle cell disease. Semin Hematol. 2001;38(Suppl 1):69–72.
  • Voskaridou E, Douskou M, Terpos E, Deferiprone as an oral iron chelator in sickle cell disease. Ann Hematol. 2005;84:434–440.
  • Vichinsky E, Onyekwere O, Porter J, A randomized comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Br J Haematol. 2006;136:501–508.
  • Rees DC, Olujohungbe AD, Parker NE, Guidelines for the management of the acute painful crisis in sickle cell disease. Br J Haematol. 2003;120:744–752.
  • Ballas SK. Treatment of pain in adults with sickle cell disease. Am J Hematol. 1990;34:49–54.
  • Rogers ZR, lieff S, McMurray M, Collaborative data project [C-DATA] of the comprehensive sickle cell centers program. Blood. 2006;108(11): Abstract 1200.
  • Cappellini MD. Overcoming the challenge of patient compliance with iron chelation therapy. Semin Hematol. 2005;42:S19–S21.
  • Treadwell M, Sung J, Murray E, Barriers to deferoxamine adherence for adults with sickle cell disease. Blood. 2004;104(11): Abstract 3760.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.